SG11201901917RA - Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance - Google Patents

Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance

Info

Publication number
SG11201901917RA
SG11201901917RA SG11201901917RA SG11201901917RA SG11201901917RA SG 11201901917R A SG11201901917R A SG 11201901917RA SG 11201901917R A SG11201901917R A SG 11201901917RA SG 11201901917R A SG11201901917R A SG 11201901917RA SG 11201901917R A SG11201901917R A SG 11201901917RA
Authority
SG
Singapore
Prior art keywords
international
ampholyte copolymer
mol
pct
cationic
Prior art date
Application number
SG11201901917RA
Other languages
English (en)
Inventor
Frédéric Blondel
Emmanuel Aussant
Sandra Guinebretiere
Ian Michael Harrison
Guillaume Jeanson
Original Assignee
Spcm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spcm Sa filed Critical Spcm Sa
Publication of SG11201901917RA publication Critical patent/SG11201901917RA/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Fats And Perfumes (AREA)
  • Polyurethanes Or Polyureas (AREA)
SG11201901917RA 2016-09-19 2017-09-18 Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance SG11201901917RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16306196.3A EP3295929A1 (fr) 2016-09-19 2016-09-19 Utilisation de copolymère d'ampholyte comme stabilisateur colloïdal dans un procédé d'encapsulation de fragrance
PCT/EP2017/073518 WO2018050899A2 (fr) 2016-09-19 2017-09-18 Utilisation d'un copolymère ampholyte en tant que stabilisant colloïdal dans un procédé d'encapsulation de parfum

Publications (1)

Publication Number Publication Date
SG11201901917RA true SG11201901917RA (en) 2019-04-29

Family

ID=57121167

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201901917RA SG11201901917RA (en) 2016-09-19 2017-09-18 Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance

Country Status (10)

Country Link
US (1) US10758885B2 (fr)
EP (2) EP3295929A1 (fr)
JP (1) JP6980007B2 (fr)
CN (1) CN109789084B (fr)
BR (1) BR112019004886B1 (fr)
ES (1) ES2846248T3 (fr)
MX (1) MX2019002958A (fr)
PL (1) PL3515403T3 (fr)
SG (1) SG11201901917RA (fr)
WO (1) WO2018050899A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201804038D0 (en) * 2018-03-14 2018-04-25 Givaudan Sa Improvements in or realating to organic compounds
BR112020021624B1 (pt) * 2018-04-24 2024-02-06 Symrise Ag Cápsulas núcleo-casca, produto, processo para produzir as referidas cápsulas e uso dos mesmos
CN112725098B (zh) * 2020-12-28 2022-04-08 厦门琥珀日化科技股份有限公司 一种微胶囊香精洗衣液及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243273A (en) * 1991-06-28 1995-02-24 Calgon Corp Hair care compositions comprising ampholytic terpolymers
JPH05185736A (ja) * 1992-01-14 1993-07-27 Fuji Photo Film Co Ltd 金属イオン及びハロゲンイオンの含有量が少ない感熱記録材料の製造方法。
JP3208473B2 (ja) * 1994-12-15 2001-09-10 ハイモ株式会社 両性水溶性重合体分散液からなる処理剤
DE50104385D1 (de) 2000-02-23 2004-12-09 Henkel Kgaa Wasch- oder reinigungsmittel mit komponenten in form von mikro- und/oder nanokapseln
DE10024624A1 (de) 2000-05-18 2001-11-22 Bayer Ag Modifizierte Polyisocyanate
GB0114197D0 (en) * 2001-06-11 2001-08-01 Syngenta Ltd Reactive polymeric surfactants
EP1396508A1 (fr) * 2002-09-04 2004-03-10 Basf Aktiengesellschaft Préparation d'une dispersion aqueuse de homo- et copolymères cationiques utilisant des colloides protecteurs amphotéres
US20050112152A1 (en) * 2003-11-20 2005-05-26 Popplewell Lewis M. Encapsulated materials
FR2873579B1 (fr) * 2004-07-29 2006-11-03 Oreal Composition cosmetique comprenant un polyester sulfonique lineaire et un polyurethane particulier, procedes mettant en oeuvre cette composition et utilisations
EP2300146B1 (fr) * 2008-06-16 2017-03-29 Firmenich S.A. Procédé de préparation de microcapsules de polyurée
US20120148644A1 (en) 2009-09-18 2012-06-14 Lewis Michael Popplewell Encapsulated Active Materials
US10226405B2 (en) * 2009-09-18 2019-03-12 International Flavors & Fragrances Inc. Purified polyurea capsules, methods of preparation, and products containing the same
EP2553080B1 (fr) 2010-04-01 2017-08-23 The Procter and Gamble Company Procédé pour former un revêtement de polymères cationiques sur des microcapsules
BR112012029551B1 (pt) * 2010-06-11 2019-01-29 Firmenich Sa processo para preparação de microcápsulas de poliureia
ES2628087T3 (es) * 2010-06-25 2017-08-01 Cognis Ip Management Gmbh Procedimiento para producir microcápsulas
GB201010701D0 (en) 2010-06-25 2010-08-11 Givaudan Sa Process for producing microcapsules
MX361658B (es) * 2013-08-15 2018-12-13 Int Flavors & Fragrances Inc Capsulas de poliurea o poliuretano.
EP3137206B1 (fr) * 2014-04-29 2019-11-27 Basf Se Procédé pour la préparation de microcapsules
US9963661B2 (en) * 2014-06-27 2018-05-08 Firmenich Sa Hybrid perfume microcapsules
US10201795B2 (en) 2014-11-07 2019-02-12 Basf Se Microcapsules comprising hydroxyalkyl cellulose

Also Published As

Publication number Publication date
BR112019004886B1 (pt) 2022-07-12
WO2018050899A2 (fr) 2018-03-22
EP3515403A2 (fr) 2019-07-31
JP6980007B2 (ja) 2021-12-15
PL3515403T3 (pl) 2021-06-14
ES2846248T3 (es) 2021-07-28
US10758885B2 (en) 2020-09-01
EP3295929A1 (fr) 2018-03-21
CN109789084B (zh) 2022-03-08
JP2019530566A (ja) 2019-10-24
CN109789084A (zh) 2019-05-21
WO2018050899A3 (fr) 2019-04-25
BR112019004886A2 (pt) 2019-06-11
EP3515403B1 (fr) 2021-01-13
US20190255501A1 (en) 2019-08-22
MX2019002958A (es) 2019-07-04

Similar Documents

Publication Publication Date Title
SG11201908813QA (en) Anti-sirp alpha antibodies
SG11201909949XA (en) Targeted immunotolerance
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201907056XA (en) Compositions and methods for the treatment of hemoglobinopathies
SG11201806340YA (en) Zika virus vaccine
SG11201801401UA (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
SG11201811706RA (en) Process for the preparation of microcapsules
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201908977SA (en) Niraparib formulations
SG11201804916PA (en) Three-dimensional polymer networks with channels situated therein
SG11202000333UA (en) Bicyclic ketone compounds and methods of use thereof
SG11201808686VA (en) Synthesis of indazoles
SG11201809830WA (en) Selective reduction of cysteine-engineered antibodies
SG11201906041QA (en) Pharmaceutical compositions for combination therapy
SG11201907364WA (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
SG11201903061YA (en) Combination treatments comprising administration of imidazopyrazinones
SG11201900021PA (en) Methods and compositions for the treatment of cancer
SG11201808713YA (en) Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
SG11201809497RA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11201903145TA (en) Pharmaceutical complex formulation comprising amlodipine, losartan and chlorthalidone
SG11201901394XA (en) Neisseria meningitidis vaccine
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201805149XA (en) Compositions comprising 15-hepe and methods of using the same
SG11201809561WA (en) 9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (uti) treatment
SG11201901917RA (en) Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance